Blog
We’re looking for participants for an industry survey sponsored by Oracle Health Sciences. As a life sciences professional, your input is invaluable to this research project. Genomics, AI, IoT, and other new initiatives have the opportunity to revolutionize multivigilance. P … Read More »
With more companies responding to growing caseloads by using automation to streamline elements of the pharmacovigilance/multivigilance process, it’s useful for safety professionals to understand the different options available, as well as how automation today can eventually … Read More »
Sponsored by Parexel A successful FSP outsourcing model provides flexibility, control & access to a workforce with highly specialized skills & knowledge. It’s essential to evaluate & match the skill set & cultural fit of the candidate & sponsor. The Parex … Read More »
We’re looking for participants for an industry survey sponsored by Oracle Health Sciences. Genomics, AI, IoT, and other new initiatives have the opportunity to revolutionize multivigilance. Please answer this short, anonymous survey and add your voice to this key industry re … Read More »
Click here to download printable PDF The Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program instituted by the US Food and Drug Administration (FDA) in response to the COVID-19 pandemic The primary goal of the program is to expedite the availabil … Read More »
Sponsored by Covance Watch now Technology is often touted as a silver bullet, but often the promise falls short of the unrealistic expectation of a tech driven utopia. Knowing when to deploy which technologies requires a pragmatism that balances technology with people and pr … Read More »
Sponsored by Covance Register The PMSR regulations for drugs, devices, and biological products share many similarities, each set of regulations establishes distinct reporting requirements, including reporting triggers and timeframes. In this virtual webinar, expert panelists … Read More »
Recently Mariah Baltezegar, MBA, Executive Director and Head of Peri- and Post-Approval Virtual Trials with Evidera, and Niklas Morton, MSc, Senior Vice President and Global Head of Digital Services with PPD, spoke with leaders of Science 37 and Medable, two companies Evider … Read More »
By making it easier for patients to participate in research today, Parexel’s Decentralized Clinical Trials are defining a better pathway to the medicines of tomorrow. Parexel have experience of over 70 Decentralized Clinical Trials (inclusive of home nursing visits) and expe … Read More »
Download the white paper now https://bit.ly/evidera-digena Multiple strategies, each with their individual advantages and drawbacks, may be employed to answer a research question, but determining the optimal strategy – the one that will bring you to your answer in the most e … Read More »
Access the issue now https://bit.ly/evidera052020 Evidera’s biannual publication focused on the scientific, strategic, and operational challenges of today’s healthcare environment. This issue highlights a variety of topics to address our industry’s most pressing issues, such … Read More »
eSource (defined as data initially recorded in an electronic format) formats have provided excellent opportunities to not only streamline clinical research securely, but to increase data quality and trustworthiness. As these methods are continually reviewed for newer and bet … Read More »
Access the on-demand webinar now https://bit.ly/FLU-PRO The FLU-PRO is a self-administered patient-reported outcome measure (PRO) to quantify symptom severity in influenza and influenza-like illness. The instrument was developed by a team of academic investigators spanning m … Read More »
Provided by: Elligo Health Research https://www.elligohealthresearch.com/ The ongoing COVID-19 pandemic continues to highlight the need for secure virtual capabilities and decentralized/hybrid approaches to clinical research models. Not only do these solutions maintain the m … Read More »
As COVID-19 continues to escalate, we face unprecedented times ahead. Parexel’s 1000+ strong Regulatory & Access team are closely following agency announcements and new guidances. They have created a COVID-19 Resource Center to share latest news, translated guidance info … Read More »
From R&D, to pre-launch and launch phases, to post-market surveillance and commercial performance – Real-World Evidence (RWE) has shown immense value for companies that have invested the resources to track, measure, and apply it meaningfully. This infographic breaks down … Read More »
Being a nurse made Jennifer Jacobson a reluctant patient, but she learned methods for self-care that clinicians may find helpful in assisting patients with chronic diseases. A Clinical Nurse Educator at VMS BioMarketing, Jennifer has lupus and ankylosing spondylitis. It’s a … Read More »
As we move into 2020, the dynamics shaping biopharmaceutical decision-making are moving faster than ever. But constant change makes it difficult to focus and plan, showing that it’s all the more important to prepare for the future by keeping a trained eye on the major shifts … Read More »
Today, life science companies and research organizations face unique challenges related to clinical trial patient recruitment which often causes major delays and challenges for research across multiple disease states. Up to 90% of studies in the U.S. experience significant d … Read More »
As we move into 2020, the dynamics shaping biopharmaceutical decision-making are moving faster than ever. But constant change makes it difficult to focus and plan, showing that it’s all the more important to prepare for the future by keeping a trained eye on the major shifts … Read More »
